Skip to main content

Table 1 Participant characteristics

From: Development and validation of the Newcastle laryngeal hypersensitivity questionnaire

Characteristic Group 1: Discriminant analysis Group 2: Responsiveness
  N = 38 N = 44
Age M (SD) 56.11 (12.4) 60.4 (13.2)
Gender (% female) 77 73
Dominant Symptom* Cough 19 (54%) Cough 38 (86%)
Breathing 8 (23%) Breathing 4 (9%)
  Globus/swallow 2 (5%)
Globus/swallow 5 (14%)  
Smoking Yes 4 (11%) No 44 (100%)
No 28 (80%)  
Passive 3 (9%)  
Associated medical conditions/previous medical history** Reflux: 17 (49%); Asthma:10 (29%); Rhinitis: 6 (17%); History of psychiatric disorder: 5 (14%); Obstructive Sleep Apnoea: 4 (11%); unrelated comorbidities: 13 (34%). Reflux: 9 (21%); Asthma: 12 (27%); Rhinitis: 12 (27%); History of psychiatric disorder: 9 (21%); Bronchiectasis: 1 (2%); unrelated comorbidities: 5 (11)
Other treatment Asthma treatment (inhaled bronchodilators or inhaled corticosteroids): 17 (49%); Proton pump inhibitor: 19 (54%); Antihistamines: (3%); Nasal/sinus treatment: 5 (14%); Antibiotics: (11%); Continuous Positive Airway Pressure: 1 (3%); Lifestyle changes for reflux: 1 (3%). Asthma treatment 12 (27%); Proton pump inhibitor 12 (27%); antihistamines 12 (27%)
  1. Note. *Three patients had mixed symptoms. **All associated medical conditions had been treated.